1 Decitabine Market Overview 1.1 Decitabine Product Overview 1.2 Decitabine Market Segment by Type 1.2.1 10 Mg Dosage Forms 1.2.2 15 Mg Dosage Forms 1.2.3 25 Mg Dosage Forms 1.3 Global Decitabine Market Size by Type 1.3.1 Global Decitabine Market Size Overview by Type (2016-2027) 1.3.2 Global Decitabine Historic Market Size Review by Type (2016-2021) 1.3.2.1 Global Decitabine Sales Breakdown in Volume by Type (2016-2021) 1.3.2.2 Global Decitabine Sales Breakdown in Value by Type (2016-2021) 1.3.2.3 Global Decitabine Average Selling Price (ASP) by Type (2016-2021) 1.3.3 Global Decitabine Forecasted Market Size by Type (2022-2027) 1.3.3.1 Global Decitabine Sales Breakdown in Volume by Type (2022-2027) 1.3.3.2 Global Decitabine Sales Breakdown in Value by Type (2022-2027) 1.3.3.3 Global Decitabine Average Selling Price (ASP) by Type (2022-2027) 1.4 Key Regions Market Size Segment by Type 1.4.1 North America Decitabine Sales Breakdown by Type (2016-2021) 1.4.2 Europe Decitabine Sales Breakdown by Type (2016-2021) 1.4.3 Asia-Pacific Decitabine Sales Breakdown by Type (2016-2021) 1.4.4 Latin America Decitabine Sales Breakdown by Type (2016-2021) 1.4.5 Middle East and Africa Decitabine Sales Breakdown by Type (2016-2021) 2 Global Decitabine Market Competition by Company 2.1 Global Top Players by Decitabine Sales (2016-2021) 2.2 Global Top Players by Decitabine Revenue (2016-2021) 2.3 Global Top Players Decitabine Price (2016-2021) 2.4 Global Top Manufacturers Decitabine Manufacturing Base Distribution, Sales Area, Product Type 2.5 Decitabine Market Competitive Situation and Trends 2.5.1 Decitabine Market Concentration Rate (2016-2021) 2.5.2 Global 5 and 10 Largest Manufacturers by Decitabine Sales and Revenue in 2020 2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Decitabine as of 2020) 2.7 Date of Key Manufacturers Enter into Decitabine Market 2.8 Key Manufacturers Decitabine Product Offered 2.9 Mergers & Acquisitions, Expansion 3 Decitabine Status and Outlook by Region 3.1 Global Decitabine Market Size and CAGR by Region: 2016 VS 2021 VS 2026 3.2 Global Decitabine Historic Market Size by Region 3.2.1 Global Decitabine Sales in Volume by Region (2016-2021) 3.2.2 Global Decitabine Sales in Value by Region (2016-2021) 3.2.3 Global Decitabine Sales (Volume & Value) Price and Gross Margin (2016-2021) 3.3 Global Decitabine Forecasted Market Size by Region 3.3.1 Global Decitabine Sales in Volume by Region (2022-2027) 3.3.2 Global Decitabine Sales in Value by Region (2022-2027) 3.3.3 Global Decitabine Sales (Volume & Value), Price and Gross Margin (2022-2027) 4 Global Decitabine by Application 4.1 Decitabine Market Segment by Application 4.1.1 Primary MDS 4.1.2 Secondary MDS 4.2 Global Decitabine Market Size by Application 4.2.1 Global Decitabine Market Size Overview by Application (2016-2027) 4.2.2 Global Decitabine Historic Market Size Review by Application (2016-2021) 4.2.2.1 Global Decitabine Sales Breakdown in Volume, by Application (2016-2021) 4.2.2.2 Global Decitabine Sales Breakdown in Value, by Application (2016-2021) 4.2.2.3 Global Decitabine Average Selling Price (ASP) by Application (2016-2021) 4.2.3 Global Decitabine Forecasted Market Size by Application (2022-2027) 4.2.3.1 Global Decitabine Sales Breakdown in Volume, by Application (2022-2027) 4.2.3.2 Global Decitabine Sales Breakdown in Value, by Application (2022-2027) 4.2.3.3 Global Decitabine Average Selling Price (ASP) by Application (2022-2027) 4.3 Key Regions Market Size Segment by Application 4.3.1 North America Decitabine Sales Breakdown by Application (2016-2021) 4.3.2 Europe Decitabine Sales Breakdown by Application (2016-2021) 4.3.3 Asia-Pacific Decitabine Sales Breakdown by Application (2016-2021) 4.3.4 Latin America Decitabine Sales Breakdown by Application (2016-2021) 4.3.5 Middle East and Africa Decitabine Sales Breakdown by Application (2016-2021) 5 North America Decitabine by Country 5.1 North America Decitabine Historic Market Size by Country 5.1.1 North America Decitabine Sales in Volume by Country (2016-2021) 5.1.2 North America Decitabine Sales in Value by Country (2016-2021) 5.2 North America Decitabine Forecasted Market Size by Country 5.2.1 North America Decitabine Sales in Volume by Country (2022-2027) 5.2.2 North America Decitabine Sales in Value by Country (2022-2027) 6 Europe Decitabine by Country 6.1 Europe Decitabine Historic Market Size by Country 6.1.1 Europe Decitabine Sales in Volume by Country (2016-2021) 6.1.2 Europe Decitabine Sales in Value by Country (2016-2021) 6.2 Europe Decitabine Forecasted Market Size by Country 6.2.1 Europe Decitabine Sales in Volume by Country (2022-2027) 6.2.2 Europe Decitabine Sales in Value by Country (2022-2027) 7 Asia-Pacific Decitabine by Region 7.1 Asia-Pacific Decitabine Historic Market Size by Region 7.1.1 Asia-Pacific Decitabine Sales in Volume by Region (2016-2021) 7.1.2 Asia-Pacific Decitabine Sales in Value by Region (2016-2021) 7.2 Asia-Pacific Decitabine Forecasted Market Size by Region 7.2.1 Asia-Pacific Decitabine Sales in Volume by Region (2022-2027) 7.2.2 Asia-Pacific Decitabine Sales in Value by Region (2022-2027) 8 Latin America Decitabine by Country 8.1 Latin America Decitabine Historic Market Size by Country 8.1.1 Latin America Decitabine Sales in Volume by Country (2016-2021) 8.1.2 Latin America Decitabine Sales in Value by Country (2016-2021) 8.2 Latin America Decitabine Forecasted Market Size by Country 8.2.1 Latin America Decitabine Sales in Volume by Country (2022-2027) 8.2.2 Latin America Decitabine Sales in Value by Country (2022-2027) 9 Middle East and Africa Decitabine by Country 9.1 Middle East and Africa Decitabine Historic Market Size by Country 9.1.1 Middle East and Africa Decitabine Sales in Volume by Country (2016-2021) 9.1.2 Middle East and Africa Decitabine Sales in Value by Country (2016-2021) 9.2 Middle East and Africa Decitabine Forecasted Market Size by Country 9.2.1 Middle East and Africa Decitabine Sales in Volume by Country (2022-2027) 9.2.2 Middle East and Africa Decitabine Sales in Value by Country (2022-2027) 10 Company Profiles and Key Figures in Decitabine Business 10.1 Johnson & Johnson 10.1.1 Johnson & Johnson Corporation Information 10.1.2 Johnson & Johnson Introduction and Business Overview 10.1.3 Johnson & Johnson Decitabine Sales, Revenue and Gross Margin (2016-2021) 10.1.4 Johnson & Johnson Decitabine Products Offered 10.1.5 Johnson & Johnson Recent Development 10.2 Eli Lilly and Company 10.2.1 Eli Lilly and Company Corporation Information 10.2.2 Eli Lilly and Company Introduction and Business Overview 10.2.3 Eli Lilly and Company Decitabine Sales, Revenue and Gross Margin (2016-2021) 10.2.4 Johnson & Johnson Decitabine Products Offered 10.2.5 Eli Lilly and Company Recent Development 10.3 Pharmachemie B.V. 10.3.1 Pharmachemie B.V. Corporation Information 10.3.2 Pharmachemie B.V. Introduction and Business Overview 10.3.3 Pharmachemie B.V. Decitabine Sales, Revenue and Gross Margin (2016-2021) 10.3.4 Pharmachemie B.V. Decitabine Products Offered 10.3.5 Pharmachemie B.V. Recent Development 10.4 Otsuka Pharmaceutical 10.4.1 Otsuka Pharmaceutical Corporation Information 10.4.2 Otsuka Pharmaceutical Introduction and Business Overview 10.4.3 Otsuka Pharmaceutical Decitabine Sales, Revenue and Gross Margin (2016-2021) 10.4.4 Otsuka Pharmaceutical Decitabine Products Offered 10.4.5 Otsuka Pharmaceutical Recent Development 10.5 Sandoz 10.5.1 Sandoz Corporation Information 10.5.2 Sandoz Introduction and Business Overview 10.5.3 Sandoz Decitabine Sales, Revenue and Gross Margin (2016-2021) 10.5.4 Sandoz Decitabine Products Offered 10.5.5 Sandoz Recent Development 10.6 Dr Reddy's Laboratories 10.6.1 Dr Reddy's Laboratories Corporation Information 10.6.2 Dr Reddy's Laboratories Introduction and Business Overview 10.6.3 Dr Reddy's Laboratories Decitabine Sales, Revenue and Gross Margin (2016-2021) 10.6.4 Dr Reddy's Laboratories Decitabine Products Offered 10.6.5 Dr Reddy's Laboratories Recent Development 10.7 Accord Healthcare 10.7.1 Accord Healthcare Corporation Information 10.7.2 Accord Healthcare Introduction and Business Overview 10.7.3 Accord Healthcare Decitabine Sales, Revenue and Gross Margin (2016-2021) 10.7.4 Accord Healthcare Decitabine Products Offered 10.7.5 Accord Healthcare Recent Development 10.8 Sun Pharmaceutical 10.8.1 Sun Pharmaceutical Corporation Information 10.8.2 Sun Pharmaceutical Introduction and Business Overview 10.8.3 Sun Pharmaceutical Decitabine Sales, Revenue and Gross Margin (2016-2021) 10.8.4 Sun Pharmaceutical Decitabine Products Offered 10.8.5 Sun Pharmaceutical Recent Development 10.9 Cipla 10.9.1 Cipla Corporation Information 10.9.2 Cipla Introduction and Business Overview 10.9.3 Cipla Decitabine Sales, Revenue and Gross Margin (2016-2021) 10.9.4 Cipla Decitabine Products Offered 10.9.5 Cipla Recent Development 10.10 Lupin 10.10.1 Company Basic Information, Manufacturing Base and Competitors 10.10.2 Decitabine Product Category, Application and Specification 10.10.3 Lupin Decitabine Sales, Revenue, Price and Gross Margin (2016-2021) 10.10.4 Main Business Overview 10.10.5 Lupin Recent Development 10.11 Shandong Xinshidai Pharmaceutical 10.11.1 Shandong Xinshidai Pharmaceutical Corporation Information 10.11.2 Shandong Xinshidai Pharmaceutical Introduction and Business Overview 10.11.3 Shandong Xinshidai Pharmaceutical Decitabine Sales, Revenue and Gross Margin (2016-2021) 10.11.4 Shandong Xinshidai Pharmaceutical Decitabine Products Offered 10.11.5 Shandong Xinshidai Pharmaceutical Recent Development 10.12 Hangzhou Zhongmei Huadong Pharmaceutical 10.12.1 Hangzhou Zhongmei Huadong Pharmaceutical Corporation Information 10.12.2 Hangzhou Zhongmei Huadong Pharmaceutical Introduction and Business Overview 10.12.3 Hangzhou Zhongmei Huadong Pharmaceutical Decitabine Sales, Revenue and Gross Margin (2016-2021) 10.12.4 Hangzhou Zhongmei Huadong Pharmaceutical Decitabine Products Offered 10.12.5 Hangzhou Zhongmei Huadong Pharmaceutical Recent Development 10.13 ZHENGDA Tianqing Pharmaceutical Group 10.13.1 ZHENGDA Tianqing Pharmaceutical Group Corporation Information 10.13.2 ZHENGDA Tianqing Pharmaceutical Group Introduction and Business Overview 10.13.3 ZHENGDA Tianqing Pharmaceutical Group Decitabine Sales, Revenue and Gross Margin (2016-2021) 10.13.4 ZHENGDA Tianqing Pharmaceutical Group Decitabine Products Offered 10.13.5 ZHENGDA Tianqing Pharmaceutical Group Recent Development 10.14 Jiangsu Aosaikang Pharmaceutical 10.14.1 Jiangsu Aosaikang Pharmaceutical Corporation Information 10.14.2 Jiangsu Aosaikang Pharmaceutical Introduction and Business Overview 10.14.3 Jiangsu Aosaikang Pharmaceutical Decitabine Sales, Revenue and Gross Margin (2016-2021) 10.14.4 Jiangsu Aosaikang Pharmaceutical Decitabine Products Offered 10.14.5 Jiangsu Aosaikang Pharmaceutical Recent Development 10.15 Jiangsu Haosen Pharmaceutical Group 10.15.1 Jiangsu Haosen Pharmaceutical Group Corporation Information 10.15.2 Jiangsu Haosen Pharmaceutical Group Introduction and Business Overview 10.15.3 Jiangsu Haosen Pharmaceutical Group Decitabine Sales, Revenue and Gross Margin (2016-2021) 10.15.4 Jiangsu Haosen Pharmaceutical Group Decitabine Products Offered 10.15.5 Jiangsu Haosen Pharmaceutical Group Recent Development 10.16 Lianyungang Jierui Pharmaceutical 10.16.1 Lianyungang Jierui Pharmaceutical Corporation Information 10.16.2 Lianyungang Jierui Pharmaceutical Introduction and Business Overview 10.16.3 Lianyungang Jierui Pharmaceutical Decitabine Sales, Revenue and Gross Margin (2016-2021) 10.16.4 Lianyungang Jierui Pharmaceutical Decitabine Products Offered 10.16.5 Lianyungang Jierui Pharmaceutical Recent Development 10.17 Qilu Pharmaceutical Hainan 10.17.1 Qilu Pharmaceutical Hainan Corporation Information 10.17.2 Qilu Pharmaceutical Hainan Introduction and Business Overview 10.17.3 Qilu Pharmaceutical Hainan Decitabine Sales, Revenue and Gross Margin (2016-2021) 10.17.4 Qilu Pharmaceutical Hainan Decitabine Products Offered 10.17.5 Qilu Pharmaceutical Hainan Recent Development 10.18 Lianyungang Runzhong Pharmaceutical 10.18.1 Lianyungang Runzhong Pharmaceutical Corporation Information 10.18.2 Lianyungang Runzhong Pharmaceutical Introduction and Business Overview 10.18.3 Lianyungang Runzhong Pharmaceutical Decitabine Sales, Revenue and Gross Margin (2016-2021) 10.18.4 Lianyungang Runzhong Pharmaceutical Decitabine Products Offered 10.18.5 Lianyungang Runzhong Pharmaceutical Recent Development 11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis 11.1 Decitabine Key Raw Materials 11.1.1 Key Raw Materials 11.1.2 Key Raw Materials Price 11.1.3 Raw Materials Key Suppliers 11.2 Manufacturing Cost Structure 11.2.1 Raw Materials 11.2.2 Labor Cost 11.2.3 Manufacturing Expenses 11.3 Decitabine Industrial Chain Analysis 11.4 Decitabine Market Dynamics 11.4.1 Industry Trends 11.4.2 Market Drivers 11.4.3 Market Challenges 11.4.4 Market Restraints 12 Market Strategy Analysis, Distributors 12.1 Sales Channel 12.2 Decitabine Distributors 12.3 Decitabine Downstream Customers 13 Research Findings and Conclusion 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.1.1 Research Programs/Design 14.1.1.2 Market Size Estimation 14.1.1.3 Market Breakdown and Data Triangulation 14.1.2 Data Source 14.1.2.1 Secondary Sources 14.1.2.2 Primary Sources 14.2 Author Details 14.3 Disclaimer

List of Tables Table 1. Major Company of 10 Mg Dosage Forms Table 2. Major Company of 15 Mg Dosage Forms Table 3. Major Company of 25 Mg Dosage Forms Table 4. Global Decitabine Sales by Type 2016 VS 2021 VS 2027 (US$ Million) Table 5. Global Decitabine Sales by Type (2016-2021) & (K Units) Table 6. Global Decitabine Sales Market Share in Volume by Type (2016-2021) Table 7. Global Decitabine Sales by Type (2016-2021) & (US& Million) Table 8. Global Decitabine Market Share in Value by Type (2016-2021) Table 9. Global Decitabine Price by Type (2016-2021) & (US$/Unit) Table 10. Global Decitabine Sales by Type (2022-2027) & (K Units) Table 11. Global Decitabine Sales Market Share in Volume by Type (2022-2027) Table 12. Global Decitabine Sales by Type (2022-2027) & (US$ Million) Table 13. Global Decitabine Sales Market Share in Value by Type (2022-2027) Table 14. Global Decitabine Price by Type (2022-2027) & (US$/Unit) Table 15. North America Decitabine Sales by Type (2016-2021) & (K Units) Table 16. North America Decitabine Sales by Type (2016-2021) & (US$ Million) Table 17. Europe Decitabine Sales (K Units) by Type (2016-2021) Table 18. Europe Decitabine Sales by Type (2016-2021) & (US$ Million) Table 19. Asia-Pacific Decitabine Sales (K Units) by Type (2016-2021) Table 20. Asia-Pacific Decitabine Sales by Type (2016-2021) & (US$ Million) Table 21. Latin America Decitabine Sales (K Units) by Type (2016-2021) Table 22. Latin America Decitabine Sales by Type (2016-2021) & (US$ Million) Table 23. Middle East and Africa Decitabine Sales (K Units) by Type (2016-2021) Table 24. Middle East and Africa Decitabine Sales by Type (2016-2021) & (US$ Million) Table 25. Global Decitabine Sales by Company (2016-2021) & (K Units) Table 26. Global Decitabine Sales Share by Company (2016-2021) Table 27. Global Decitabine Revenue by Company (2016-2021) & (US$ Million) Table 28. Global Decitabine Revenue Share by Company (2016-2021) Table 29. Global Market Decitabine Price by Company (2016-2021) & (US$/Unit) Table 30. Global Decitabine Top Manufacturers Manufacturing Base Distribution and Sales Area Table 31. Global Decitabine Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Decitabine as of 2020 Table 33. Date of Key Manufacturers Enter into Decitabine Market Table 34. Key Manufacturers Decitabine Product Type Table 35. Mergers & Acquisitions, Expansion Plans Table 36. Global Decitabine Market Size Comparison by Region (US$ Million): 2016 VS 2021 VS 2027 Table 37. Global Decitabine Sales by Region (2016-2021) & (K Units) Table 38. Global Decitabine Sales Market Share in Volume by Region (2016-2021) Table 39. Global Decitabine Sales by Region (2016-2021) & (US$ Million) Table 40. Global Decitabine Sales Market Share in Value by Region (2016-2021) Table 41. Global Decitabine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 42. Global Decitabine Sales by Region (2022-2027) & (K Units) Table 43. Global Decitabine Sales Market Share in Volume by Region (2022-2027) Table 44. Global Decitabine Sales by Region (2022-2027) & (US$ Million) Table 45. Global Decitabine Sales Market Share in Value by Region (2022-2027) Table 46. Global Decitabine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2022-2027) Table 47. Global Decitabine Sales by Application: 2016 VS 2021 VS 2027 (US$ Million) Table 48. Global Decitabine Sales by Application (2016-2021) & (K Units) Table 49. Global Decitabine Sales Market Share in Volume by Application (2016-2021) Table 50. Global Decitabine Sales by Application (2016-2021) & (US$ Million) Table 51. Global Decitabine Sales Market Share in Value by Application (2016-2021) Table 52. Global Decitabine Price by Application (2016-2021) & (US$/Unit) Table 53. Global Decitabine Sales by Application (2022-2027) & (K Units) Table 54. Global Decitabine Sales Market Share in Volume by Application (2022-2027) Table 55. Global Decitabine Sales by Application (2022-2027) & (US$ Million) Table 56. Global Decitabine Sales Market Share in Value by Application (2022-2027) Table 57. Global Decitabine Price by Application (2022-2027) & (US$/Unit) Table 58. North America Decitabine Sales by Application (2016-2021) (K Units) Table 59. North America Decitabine Sales by Application (2016-2021) & (US$ Million) Table 60. North America Decitabine Sales Market Share in Value by Application in 2020 Table 61. Europe Decitabine Sales by Application (2016-2021) (K Units) Table 62. Europe Decitabine Sales by Application (2016-2021) & (US$ Million) Table 63. Europe Decitabine Sales Market Share in Value by Application in 2020 Table 64. Asia-Pacific Decitabine Sales by Application (2016-2021) (K Units) Table 65. Asia-Pacific Decitabine Sales by Application (2016-2021) & (US$ Million) Table 66. Asia-Pacific Decitabine Sales Market Share in Value by Application in 2020 Table 67. Latin America Decitabine Sales by Application (2016-2021) (K Units) Table 68. Latin America Decitabine Sales by Application (2016-2021) & (US$ Million) Table 69. Latin America Decitabine Sales Market Share in Value by Application in 2020 Table 70. Middle East and Africa Decitabine Sales by Application (2016-2021) (K Units) Table 71. Middle East and Africa Decitabine Sales by Application (2016-2021) & (US$ Million) Table 72. Middle East and Africa Decitabine Sales Market Share in Value by Application in 2020 Table 73. North America Decitabine Sales by Country (2016-2021) & (K Units) Table 74. North America Decitabine Sales Market Share in Volume by Country (2016-2021) Table 75. North America Decitabine Sales by Country (2016-2021) & (US$ Million) Table 76. North America Decitabine Sales Market Share in Value by Country (2016-2021) Table 77. North America Decitabine Sales by Country (2022-2027) & (K Units) Table 78. North America Decitabine Sales Market Share in Volume by Country (2022-2027) Table 79. North America Decitabine Sales by Country (2022-2027) & (US$ Million) Table 80. North America Decitabine Sales Market Share in Value by Country (2022-2027) Table 81. Europe Decitabine Sales by Country (2016-2021) & (K Units) Table 82. Europe Decitabine Sales Market Share in Volume by Country (2016-2021) Table 83. Europe Decitabine Sales by Country (2016-2021) & (US$ Million) Table 84. Europe Decitabine Sales Market Share in Value by Country (2016-2021) Table 85. Europe Decitabine Sales by Country (2022-2027) & (K Units) Table 86. Europe Decitabine Sales Market Share in Volume by Country (2022-2027) Table 87. Europe Decitabine Sales by Country (2022-2027) & (US$ Million) Table 88. Europe Decitabine Sales Market Share in Value by Country (2022-2027) Table 89. Asia-Pacific Decitabine Sales by Region (2016-2021) & (K Units) Table 90. Asia-Pacific Decitabine Sales Market Share in Volume by Region (2016-2021) Table 91. Asia-Pacific Decitabine Sales by Region (2016-2021) & (US$ Million) Table 92. Asia-Pacific Decitabine Sales Market Share in Value by Region (2016-2021) Table 93. Asia-Pacific Decitabine Sales by Region (2022-2027) & (K Units) Table 94. Asia-Pacific Decitabine Sales Market Share in Volume by Region (2022-2027) Table 95. Asia-Pacific Decitabine Sales by Region (2022-2027) & (US$ Million) Table 96. Asia-Pacific Decitabine Sales Market Share in Value by Region (2022-2027) Table 97. Latin America Decitabine Sales by Country (2016-2021) & (K Units) Table 98. Latin America Decitabine Sales Market Share in Volume by Country (2016-2021) Table 99. Latin America Decitabine Sales by Country (2016-2021) & (US$ Million) Table 100. Latin America Decitabine Sales Market Share in Value by Country (2016-2021) Table 101. Latin America Decitabine Sales by Country (2022-2027) & (K Units) Table 102. Latin America Decitabine Sales Market Share in Volume by Country (2022-2027) Table 103. Latin America Decitabine Sales by Country (2022-2027) & (US$ Million) Table 104. Latin America Decitabine Sales Market Share in Value by Country (2022-2027) Table 105. Middle East and Africa Decitabine Sales by Country (2016-2021) & (K Units) Table 106. Middle East and Africa Decitabine Sales Market Share in Volume by Country (2016-2021) Table 107. Middle East and Africa Decitabine Sales by Country (2016-2021) & (US$ Million) Table 108. Middle East and Africa Decitabine Sales Market Share in Value by Country (2016-2021) Table 109. Middle East and Africa Decitabine Sales by Country (2022-2027) & (K Units) Table 110. Middle East and Africa Decitabine Sales Market Share in Volume by Country (2022-2027) Table 111. Middle East and Africa Decitabine Sales by Country (2022-2027) & (US$ Million) Table 112. Middle East and Africa Decitabine Sales Market Share in Value by Country (2022-2027) Table 113. Johnson & Johnson Corporation Information Table 114. Johnson & Johnson Introduction and Business Overview Table 115. Johnson & Johnson Decitabine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 116. Johnson & Johnson Decitabine Product Table 117. Johnson & Johnson Recent Development Table 118. Eli Lilly and Company Corporation Information Table 119. Eli Lilly and Company Introduction and Business Overview Table 120. Eli Lilly and Company Decitabine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 121. Eli Lilly and Company Decitabine Product Table 122. Eli Lilly and Company Recent Development Table 123. Pharmachemie B.V. Corporation Information Table 124. Pharmachemie B.V. Introduction and Business Overview Table 125. Pharmachemie B.V. Decitabine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 126. Pharmachemie B.V. Decitabine Product Table 127. Pharmachemie B.V. Recent Development Table 128. Otsuka Pharmaceutical Corporation Information Table 129. Otsuka Pharmaceutical Introduction and Business Overview Table 130. Otsuka Pharmaceutical Decitabine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 131. Otsuka Pharmaceutical Decitabine Product Table 132. Otsuka Pharmaceutical Recent Development Table 133. Sandoz Corporation Information Table 134. Sandoz Introduction and Business Overview Table 135. Sandoz Decitabine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 136. Sandoz Decitabine Product Table 137. Sandoz Recent Development Table 138. Dr Reddy's Laboratories Corporation Information Table 139. Dr Reddy's Laboratories Introduction and Business Overview Table 140. Dr Reddy's Laboratories Decitabine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 141. Dr Reddy's Laboratories Decitabine Product Table 142. Dr Reddy's Laboratories Recent Development Table 143. Accord Healthcare Corporation Information Table 144. Accord Healthcare Introduction and Business Overview Table 145. Accord Healthcare Decitabine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 146. Accord Healthcare Decitabine Product Table 147. Accord Healthcare Recent Development Table 148. Sun Pharmaceutical Corporation Information Table 149. Sun Pharmaceutical Introduction and Business Overview Table 150. Sun Pharmaceutical Decitabine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 151. Sun Pharmaceutical Decitabine Product Table 152. Sun Pharmaceutical Recent Development Table 153. Cipla Corporation Information Table 154. Cipla Introduction and Business Overview Table 155. Cipla Decitabine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 156. Cipla Decitabine Product Table 157. Cipla Recent Development Table 158. Lupin Corporation Information Table 159. Lupin Introduction and Business Overview Table 160. Lupin Decitabine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 161. Lupin Decitabine Product Table 162. Lupin Recent Development Table 163. Shandong Xinshidai Pharmaceutical Corporation Information Table 164. Shandong Xinshidai Pharmaceutical Introduction and Business Overview Table 165. Shandong Xinshidai Pharmaceutical Decitabine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 166. Shandong Xinshidai Pharmaceutical Decitabine Product Table 167. Shandong Xinshidai Pharmaceutical Recent Development Table 168. Hangzhou Zhongmei Huadong Pharmaceutical Corporation Information Table 169. Hangzhou Zhongmei Huadong Pharmaceutical Introduction and Business Overview Table 170. Hangzhou Zhongmei Huadong Pharmaceutical Decitabine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 171. Hangzhou Zhongmei Huadong Pharmaceutical Decitabine Product Table 172. Hangzhou Zhongmei Huadong Pharmaceutical Recent Development Table 173. ZHENGDA Tianqing Pharmaceutical Group Corporation Information Table 174. ZHENGDA Tianqing Pharmaceutical Group Introduction and Business Overview Table 175. ZHENGDA Tianqing Pharmaceutical Group Decitabine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 176. ZHENGDA Tianqing Pharmaceutical Group Decitabine Product Table 177. ZHENGDA Tianqing Pharmaceutical Group Recent Development Table 178. Jiangsu Aosaikang Pharmaceutical Corporation Information Table 179. Jiangsu Aosaikang Pharmaceutical Introduction and Business Overview Table 180. Jiangsu Aosaikang Pharmaceutical Decitabine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 181. Jiangsu Aosaikang Pharmaceutical Decitabine Product Table 182. Jiangsu Aosaikang Pharmaceutical Recent Development Table 183. Jiangsu Haosen Pharmaceutical Group Corporation Information Table 184. Jiangsu Haosen Pharmaceutical Group Introduction and Business Overview Table 185. Jiangsu Haosen Pharmaceutical Group Decitabine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 186. Jiangsu Haosen Pharmaceutical Group Decitabine Product Table 187. Jiangsu Haosen Pharmaceutical Group Recent Development Table 188. Lianyungang Jierui Pharmaceutical Corporation Information Table 189. Lianyungang Jierui Pharmaceutical Introduction and Business Overview Table 190. Lianyungang Jierui Pharmaceutical Decitabine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 191. Lianyungang Jierui Pharmaceutical Decitabine Product Table 192. Lianyungang Jierui Pharmaceutical Recent Development Table 193. Qilu Pharmaceutical Hainan Corporation Information Table 194. Qilu Pharmaceutical Hainan Introduction and Business Overview Table 195. Qilu Pharmaceutical Hainan Decitabine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 196. Qilu Pharmaceutical Hainan Decitabine Product Table 197. Qilu Pharmaceutical Hainan Recent Development Table 198. Lianyungang Runzhong Pharmaceutical Corporation Information Table 199. Lianyungang Runzhong Pharmaceutical Introduction and Business Overview Table 200. Lianyungang Runzhong Pharmaceutical Decitabine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 201. Lianyungang Runzhong Pharmaceutical Decitabine Product Table 202. Lianyungang Runzhong Pharmaceutical Recent Development Table 203. Key Raw Materials Lists Table 204. Raw Materials Key Suppliers Lists Table 205. Decitabine Market Trends Table 206. Decitabine Market Drivers Table 207. Decitabine Market Challenges Table 208. Decitabine Market Restraints Table 209. Decitabine Distributors List Table 210. Decitabine Downstream Customers Table 211. Research Programs/Design for This Report Table 212. Key Data Information from Secondary Sources Table 213. Key Data Information from Primary Sources List of Figures Figure 1. Decitabine Product Picture Figure 2. Global Decitabine Market Size, 2016 VS 2021 VS 2027 (US$ Million) Figure 3. Global Decitabine Market Size Status and Outlook (2016-2027) & (US$ Million) Figure 4. Global Decitabine Sales Status and Outlook (2016-2027) & (K Units) Figure 5. Product Picture of 10 Mg Dosage Forms Figure 6. Global 10 Mg Dosage Forms Sales YoY Growth (2016-2021) & (K Units) Figure 7. Product Picture of 15 Mg Dosage Forms Figure 8. Global 15 Mg Dosage Forms Sales YoY Growth (2016-2021) & (K Units) Figure 9. Product Picture of 25 Mg Dosage Forms Figure 10. Global 25 Mg Dosage Forms Sales YoY Growth (2016-2021) & (K Units) Figure 11. Global Decitabine Sales by Type (2016-2027) & (US$ Million) Figure 12. Global Decitabine Sales Market Share in Volume by Type (2016-2021) Figure 13. Global Decitabine Sales Market Share in Value by Type (2016-2021) Figure 14. Global Decitabine Sales Market Share in Volume by Type (2022-2027) Figure 15. Global Decitabine Sales Market Share in Value by Type (2022-2027) Figure 16. North America Decitabine Sales Market Share in Volume by Type in 2020 Figure 17. North America Decitabine Sales Market Share in Value by Type in 2020 Figure 18. Europe Decitabine Sales Market Share in Volume by Type in 2020 Figure 19. Europe Decitabine Sales Market Share in Value by Type in 2020 Figure 20. Asia-Pacific Decitabine Sales Market Share in Volume by Type in 2020 Figure 21. Asia-Pacific Decitabine Sales Market Share in Value by Type in 2020 Figure 22. Latin America Decitabine Sales Market Share in Volume by Type in 2020 Figure 23. Latin America Decitabine Sales Market Share in Value by Type in 2020 Figure 24. Middle East and Africa Decitabine Sales Market Share in Volume by Type in 2020 Figure 25. Middle East and Africa Decitabine Sales Market Share in Value by Type in 2020 Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Decitabine Sales in 2020 Figure 27. The 5 and 10 Largest Manufacturers in the World: Market Share by Decitabine Revenue in 2020 Figure 28. Decitabine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020 Figure 29. Product Picture of Primary MDS Figure 30. Global Primary MDS Sales YoY Growth (2016-2027) & (K Units) Figure 31. Product Picture of Secondary MDS Figure 32. Global Secondary MDS Sales YoY Growth (2016-2027) & (K Units) Figure 33. Global Decitabine Sales by Application (2016-2027) & (US$ Million) Figure 34. Global Decitabine Sales Market Share in Volume by Application (2016-2021) Figure 35. Global Decitabine Sales Market Share in Value by Application (2016-2021) Figure 36. Global Decitabine Sales Market Share in Volume by Application (2022-2027) Figure 37. North America Decitabine Sales Market Share in Volume by Application in 2020 Figure 38. Latin America Decitabine Sales Market Share in Value by Application in 2020 Figure 39. Middle East and Africa Decitabine Sales Market Share in Value by Application in 2020 Figure 40. Key Raw Materials Price Figure 41. Decitabine Manufacturing Cost Structure Figure 42. Decitabine Industrial Chain Analysis Figure 43. Channels of Distribution Figure 44. Distributors Profiles Figure 45. Bottom-up and Top-down Approaches for This Report Figure 46. Data Triangulation Figure 47. Key Executives Interviewed

Johnson & Johnson Eli Lilly and Company Pharmachemie B.V. Otsuka Pharmaceutical Sandoz Dr Reddy's Laboratories Accord Healthcare Sun Pharmaceutical Cipla Lupin Shandong Xinshidai Pharmaceutical Hangzhou Zhongmei Huadong Pharmaceutical ZHENGDA Tianqing Pharmaceutical Group Jiangsu Aosaikang Pharmaceutical Jiangsu Haosen Pharmaceutical Group Lianyungang Jierui Pharmaceutical Qilu Pharmaceutical Hainan Lianyungang Runzhong Pharmaceutical